Mike McCully, Gate Neurosciences CEO
Recently out-of-stealth neuroscience outfit unveils cash raise, more details on Lilly, Northwestern programs
Gate Neurosciences, well, came out of the gate in late August with a lineup of drugs, known as NMDA receptor modulators, for major depressive disorder …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
